Published: August 2, 2021
Stymied and disoriented. Thats one way to describe the state of the immune system in some patients with cancer. T cells revved up to attack tumors are turned into an army of loiterers. Cells keenly attuned to signals of infection or disease fail to pick up the faint notes of cancer.
A clinical trial led by Dana-Farber researchers is addressing both of these issues in patients who have undergone surgery for kidney cancer but have a high risk of recurrence. Patients in the trial receive the latest generation of NeoVax, a personalized vaccine made from tiny bits of each patients tumor cells. They also are treated with a local injection of an immune checkpoint inhibitor, which liberates a specific group of T cells to take up an assault on tumor cells.
In the words of David Braun, MD, PhD, the principal investigator of the trial (with Toni Choueiri, MD, and Patrick Ott, MD, PhD), the checkpoint inhibitor releases the brakes on the immune response while the personalized vaccine makes it possible to steer the immune system specifically to a patients tumor.
The dual approach seeks to improve on the results achieved by either treatment alone. Checkpoint inhibitors, which have transformed the treatment of some cancers, have had little success against others. NeoVax, developed by Dana-Farbers Catherine Wu, MD, and her colleagues, has performed well in clinical trials, but its potential has only begun to be explored.
Patients with advanced kidney cancer are in need of better treatments to prevent the return of their disease and particularly stand to benefit from this combination, Braun remarks.
Even after surgery to remove the kidney, where a patient might have no evidence of disease on imaging, patients with stage III or IV cancer are at high risk of recurrence. Right now, the tools we have to lower that risk are limited.
Richard Boylan is one of those who, in the absence of the trial, would have faced a dearth of options to prevent his cancer from coming back. Diagnosed with stage III kidney cancer in mid-2019, Boylan, 67, learned about the trial from his local surgeon.
He explained that the trial would be integrated with the surgery, says Boylan, of Holliston, Mass. When the tumor was removed in October, it was sent to Dana-Farber for analysis.
At the Institute, technicians sequenced the DNA in the tumor and in a sample of Boylans blood to identify the genetic changes that distinguished the tumor cells from the bodys normal cells. Specialists used bioinformatics to predict which of these changes, or mutations, were most likely to trigger an immune response.
We pick the top 20 targets and make millions of copies of each one in the form of peptides, short chains of amino acids, that stimulate the immune system, Braun explains. We then inject these peptides, which constitute the NeoVax vaccine, into patients.
The peptides are paired with low doses of a local injection of a checkpoint inhibitor. The hope is we can lift the brakes just enough to stir the immune response without producing adverse effects, Braun notes.
In February and June of 2020, Boylan underwent leukapheresis procedures, which separate out white blood cells from the rest of the blood. The first one was done prior to treatment with NeoVax, the second one after. Each sample of white blood cells would be mixed with tumor cells in what Boylan calls a laboratory cage match to see if the cells in the second sample, enriched with tumor cell peptides, mount a fiercer attack on the cancer than cells in the first sample.
The trial itself involved a lot of shots, a lot of needles, over an extended period, Boylan remarks, adding, I am not a big fan of needles.
At each treatment session, Boylan received three shots in each arm and each leg. Two of those three shots consisted of the peptides, the other was an immune stimulant. (The trial involves targeting many different mutations or neoantigens; hence the injections in each limb.)
The only noteworthy side effect, Boylan says, came when he was receiving the vaccine every week.
Some of them would knock me back for at least 24 hours it felt like having the flu. But, honestly, the side effects from my most recent shingles shot were worse than those from the vaccine.
The trial is supported by Gateway for Cancer Research, and the laboratory-based research is supported by the Department of Defense Congressionally-Directed Medical Research Program. As the trial is still underway, effectiveness of the regimen hasnt been analyzed, but Boylan has picked up some promising signs.
For some patients, theres a 40% risk of recurrence over an extended period of time, he says, but you can tell by the enthusiasm you hear in talking to the doctors how well the study is going.
Go here to read the rest:
Study Pairs Two Forms of Immunotherapy in Patients with Advanced Kidney Cancer | Dana-Farber - Dana-Farber Cancer Institute
- Neutrophil diversity and function in health and disease - Nature.com - December 6th, 2024
- Harnessing the Power of the Immune System for Breast Cancer Treatment - Breast Cancer Research Foundation - December 6th, 2024
- Study Examines Neoantigen Landscapes and Their Role in Immunotherapy Efficacy - Consult QD - December 6th, 2024
- The 5 Best Teas to Support Your Immune System This Cold & Flu Season - EatingWell - December 6th, 2024
- Engineered immune cells may be able to tame inflammation - Medical Xpress - December 6th, 2024
- Hybrid model of tumor growth, angiogenesis and immune response yields strategies to improve antiangiogenic therapy - Nature.com - December 6th, 2024
- Opioids interfere with cancer immunotherapy, but another type of drug could help - Medical Xpress - December 6th, 2024
- RANKL cytokine restores thymus cells in old mice, reducing tumor growth and improving T cell immune response - Fierce Biotech - December 6th, 2024
- Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in... - December 6th, 2024
- Immuno-Oncology Strategic Industry Research Report 2023-2024 & 2030: Approval of Pembrolizumab (Keytruda) and Nivolumab (Opdivo), which Target... - December 6th, 2024
- Study cracks the cold case of immunotherapy resistance - News-Medical.Net - December 6th, 2024
- New immune therapy improves survival and reduces tumor burden in glioblastoma - News-Medical.Net - December 6th, 2024
- Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis - Nature.com - December 6th, 2024
- Immune Cell Breakthrough: Scientists Discover a Hidden Ally in the Fight Against Cancer - SciTechDaily - December 6th, 2024
- Rising temperatures impact the immune system of wild monkeys - Earth.com - December 6th, 2024
- Study declaring Alzheimer's to be a "brain disease" proven to be fabricated - Earth.com - December 6th, 2024
- Warming temperatures impact immune performance of wild monkeys, U-M study shows - University of Michigan News - December 6th, 2024
- New study explores heart risks of cancer immunotherapy - News-Medical.Net - December 6th, 2024
- 'Incredible' way to boost your immune system naturally and ward of colds and flu this winter - The Mirror - December 6th, 2024
- Tis the Season to Boost Your Immune System - Mix93.3 - December 6th, 2024
- A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies - Nature.com - October 14th, 2024
- Fox Chase Cancer Center Researchers Find Gene That Triggers Immune Response in Treatment-Resistant Small-Cell Lung Cancer - Fox Chase Cancer Center - October 14th, 2024
- What Does It Mean to Be Immunocompromised? - The New York Times - October 14th, 2024
- Scientist hopes to cure Type 1 diabetes by disguising stem cells - The University of Arizona - October 14th, 2024
- Watching an infection unfold with a sphingolipid probe - Drug Discovery News - October 14th, 2024
- The cells that protect your brain against infection could also be behind some chronic diseases - BBC.com - October 14th, 2024
- On Nutrition: Foods that help strengthen the immune system - LimaOhio.com - October 14th, 2024
- An integral T cell pathway has implications for understanding sex-based immune response - Medical Xpress - October 14th, 2024
- Immune Response Linked to Lewy Body Formation - Neuroscience News - October 14th, 2024
- Are vaccines the future of cancer prevention? - Genetic Literacy Project - October 14th, 2024
- The Gut Microbiome and Autoimmunity - Inside Precision Medicine - October 14th, 2024
- Researchers discover how oral cancer cells may block the body's immune response - News-Medical.Net - September 21st, 2024
- Are Vaccines More Effective When You Believe in Them? - Greater Good Science Center at UC Berkeley - September 21st, 2024
- Researchers discover immune response to dengue can predict risk of severe reinfections - Medical Xpress - September 21st, 2024
- Texas Researchers Find Acid Walls That Shield Cancer Tumors from Bodys Immune System Response - DARKDaily.com - Laboratory News - September 21st, 2024
- Lysosomes in the immunometabolic reprogramming of immune cells in atherosclerosis - Nature.com - September 21st, 2024
- A new way to reprogram immune cells and direct them toward anti-tumor immunity - MIT News - September 21st, 2024
- Unravelling the many mysteries of the immune system - Cosmos - September 21st, 2024
- Long COVID patients maintain robust immune memory two years after infection - News-Medical.Net - September 21st, 2024
- Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other viral infections - Journal of... - September 21st, 2024
- Which adults benefit from the pneumococcal vaccine? - Mayo Clinic Press - September 21st, 2024
- UAMS receives $2.2 million grant to study immune response to eye disease - talkbusiness.net - September 21st, 2024
- Low oxygen levels in tumors could enhance some of the body's immune responses against cancer - Medical Xpress - September 21st, 2024
- Overview of the Immune System - The Merck Manuals - March 18th, 2024
- What are the organs of the immune system? - InformedHealth.org - NCBI ... - January 17th, 2024
- Mom who homeschools her children reveals she lets her one-year-old play in and EAT mud - but insists it is goo - Daily Mail - November 26th, 2023
- The limits of nutritional supplements: they dont cure or prevent ailments, nor are they harmless - EL PAS USA - November 26th, 2023
- Here's how your gut affects your mental health, immune function and even cardiovascular health - indulgexpress - November 18th, 2023
- From fear to freedom: Anchor Paul LaGrone shares his story of sudden hair loss & the disease that caused it - ABC Action News Tampa Bay - May 9th, 2023
- Strengthen Your Immune System With 4 Simple Strategies - May 1st, 2023
- Immunodeficiency Awareness Month: What Is The Science Behind These Diseases? Know Warning Signs - ABP Live - May 1st, 2023
- Nearly 90% of patients with rare skin cancer respond to therapy that prevents tumors from evading the immune - cleveland.com - April 23rd, 2023
- University of Cincinnati researchers helping develop 'vaccine' to fight aggressive cancer - WKRC TV Cincinnati - April 23rd, 2023
- Sana Biotechnology Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform and Advancements with its In Vivo Fusogen Platform with... - April 23rd, 2023
- Immune System: Parts & Common Problems - Cleveland Clinic - March 21st, 2023
- Disorders of the Immune System | Johns Hopkins Medicine - March 21st, 2023
- Sometimes 15 Minutes Are More Than Enough To Improve Immune System, Sleep Quality And Depression - Revyuh - March 13th, 2023
- People produce endocannabinoids similar to compounds found in marijuana that are critical to many bodily functions - The Conversation Indonesia - February 24th, 2023
- Spending more time with your kids, grandkidsand their germsmay lower risk of a severe outcome from Covid-19, recent studies show - CNBC - December 20th, 2022
- Published in Journal for Immunotherapy of Cancer: Using Single-Cell Analysis to Assess the Effects of an Anti-OX40 Monoclonal Antibody in Its... - November 17th, 2022
- Man who had COVID-19 for 400 days finally cured after getting treated with antibodies, study says - msnNOW - November 17th, 2022
- Social Distancing: The Impact on Your Health and Immune System - Healthline - October 7th, 2022
- Unraveling the Mysteries of the Immune System - Duke University School of Medicine - October 7th, 2022
- When Will ISR Immune System Regulation Holding AB (publ) (STO:ISR) Become Profitable? - Simply Wall St - October 7th, 2022
- VitaGaming Introduces Immune Support and Collagen to help Gamers boost immunity and fight stress - PR Web - October 7th, 2022
- Ohio reports third U.S. death of person with monkeypox who had underlying health conditions - CNBC - October 7th, 2022
- How a select few people have been cured of HIV - PBS - October 7th, 2022
- BeniCaros Wins Nutrition Industry Executive 2022 Immune Health Award - GlobeNewswire - October 7th, 2022
- Seasonal superfoods to give your immune system a boost this autumn - Yahoo Entertainment - October 7th, 2022
- Whats Going Around: Flu cases confirmed locally - ABC27 - October 7th, 2022
- Contributor: How to Fight the Cold and the Flu This Season - AJMC.com Managed Markets Network - October 7th, 2022
- Updated COVID-19 Bivalent Booster Released in Time for Fall and Winter Omicron Wave - Cornell University The Cornell Daily Sun - October 7th, 2022
- Oralair pill that retrains the immune system to reduce risk of thunderstorm asthma - 7NEWS - October 7th, 2022
- COVID immune reaction could affect brain mechanisms and induce neurological symptoms - Sky News - October 7th, 2022
- 7 Surprising Health Benefits of Pumpkins - AARP - October 7th, 2022
- Why Do Some Allergies Go Away While Others Dont? - The Atlantic - October 7th, 2022
- 15 foods to boost the immune system - Medical News Today - September 4th, 2022
- The powerful supplement that could enhance your immune response to bacteria and viruses - Express - September 4th, 2022
- New research: Cancer-fighting viruses can boost body's immune response - The Indian Express - September 4th, 2022
- Long COVID: How researchers are zeroing in on the self-targeted immune attacks that may lurk behind it - The Conversation Indonesia - September 4th, 2022